These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22754008)

  • 1. l-Asparaginase Production by Moderate Halophilic Bacteria Isolated from Maharloo Salt Lake.
    Ebrahiminezhad A; Rasoul-Amini S; Ghasemi Y
    Indian J Microbiol; 2011 Jul; 51(3):307-11. PubMed ID: 22754008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of halophilic and halotolerant bacteria for the production of antineoplastic enzymes: L-asparaginase and L-glutaminase.
    Shirazian P; Asad S; Amoozegar MA
    EXCLI J; 2016; 15():268-79. PubMed ID: 27330530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and screening of extracellular anticancer enzymes from halophilic and halotolerant bacteria from different saline environments in Iran.
    Zolfaghar M; Amoozegar MA; Khajeh K; Babavalian H; Tebyanian H
    Mol Biol Rep; 2019 Jun; 46(3):3275-3286. PubMed ID: 30993582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Asparaginase Activity in Cell Lysates and Culture Media of Halophilic Bacterial Isolates.
    Barati M; Faramarzi MA; Nafissi-Varcheh N; Khoshayand MR; Houshdar Tehrani MH; Vahidi H; Adrangi S
    Iran J Pharm Res; 2016; 15(3):435-440. PubMed ID: 27980578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
    Billett AL; Carls A; Gelber RD; Sallan SE
    Cancer; 1992 Jul; 70(1):201-6. PubMed ID: 1606543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
    Larson RA; Fretzin MH; Dodge RK; Schiffer CA
    Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
    Vrooman LM; Kirov II; Dreyer ZE; Kelly M; Hijiya N; Brown P; Drachtman RA; Messinger YH; Ritchey AK; Hale GA; Maloney K; Lu Y; Plourde PV; Silverman LB
    Pediatr Blood Cancer; 2016 Feb; 63(2):228-33. PubMed ID: 26376459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
    Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erwinia asparaginase in pediatric acute lymphoblastic leukemia.
    Salzer W; Seibel N; Smith M
    Expert Opin Biol Ther; 2012 Oct; 12(10):1407-14. PubMed ID: 22946493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase produced from soil isolates of
    Fatima N; Khan MM; Khan IA
    Saudi J Biol Sci; 2019 Sep; 26(6):1146-1153. PubMed ID: 31516343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antineoplastic activity of extracellular asparaginase produced by isolated Bacillus circulans.
    Prakasham RS; Hymavathi M; Subba Rao Ch; Arepalli SK; Venkateswara Rao J; Kennady PK; Nasaruddin K; Vijayakumar JB; Sarma PN
    Appl Biochem Biotechnol; 2010 Jan; 160(1):72-80. PubMed ID: 19543838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients.
    Wang B; Relling MV; Storm MC; Woo MH; Ribeiro R; Pui CH; Hak LJ
    Leukemia; 2003 Aug; 17(8):1583-8. PubMed ID: 12886246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL.
    Ali U; Naveed M; Ullah A; Ali K; Shah SA; Fahad S; Mumtaz AS
    Eur J Pharmacol; 2016 Jan; 771():199-210. PubMed ID: 26698391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.
    Yen HJ; Chang WH; Liu HC; Yeh TC; Hung GY; Wu KH; Peng CT; Chang YH; Chang TK; Hsiao CC; Sheen JM; Chao YH; Chang TT; Chiou SS; Lin PC; Wang SC; Lin MT; Ho WL; Chen YC; Liang DC
    Pediatr Blood Cancer; 2016 Apr; 63(4):665-70. PubMed ID: 26703788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
    Vrooman LM; Supko JG; Neuberg DS; Asselin BL; Athale UH; Clavell L; Kelly KM; Laverdière C; Michon B; Schorin M; Cohen HJ; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2010 Feb; 54(2):199-205. PubMed ID: 19672973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Kurtzberg J; Asselin B; Bernstein M; Buchanan GR; Pollock BH; Camitta BM
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):610-6. PubMed ID: 22042277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Community structure and diversity of culturable moderate halophilic bacteria isolated from Qrhan salt lake on Qinghai-Tibet Plateau].
    Shen S
    Wei Sheng Wu Xue Bao; 2017 Apr; 57(4):490-9. PubMed ID: 29756733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
    Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
    Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.